Tensha Therapeutics develops small molecule bromodomain inhibitors to treat cancer and other serious disorders.
Business Model:
Revenue: $0
Employees: 2-10
Tensha Therapeutics was acquired by
Roche.
The acquisition happend on 2016-01-11.
Details of the transaction were not public
Address: 55 Cambridge Pkwy
City: Cambridge
State: MA
Zip: 02142
Country: US
Tensha Therapeutics develops small molecule bromodomain inhibitors to treat cancer and other serious disorders.
Contact Phone:
+16172524343
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2011 | Series A | 1 | $15M |
HealthCare Ventures HealthCare Ventures HealthCare Ventures HealthCare Ventures |
4/2012 | Funding Round | 1 | - |
Torrey Pines Investment Torrey Pines Investment |
7/2011 | Equity | $500k |
HealthCare Ventures |
4/2012 | Funding Round | 1 | - |
Torrey Pines Investment Torrey Pines Investment |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|